These inhalers use CFCs as propellants to spray the medicine out of the inhaler so patients can breathe the medicine into their lungs.
The seven CFC inhalers are used for the treatment of asthma or chronic obstructive pulmonary disease (COPD) or both. Both diseases cause a decrease in air flow to the lungs.
More information about the phase-outand about inhalers that do not contain CFCsfollows.
Dates for the phase-out of each CFC inhaler have been set. After those dates, these CFC inhalers cannot be made, dispensed, or sold in the United States.
The seven CFC inhalers are listed here by their brand names, along with their manufacturers and the last date they can be sold in the United States. The generic names for the medicines appear in parentheses.
Tilade Inhaler (nedocromil), made by King Pharmaceuticals, last date for sale: June 14, 2010
Alupent Inhalation Aerosol (metaproterenol), made by Boehringer Ingelheim Pharmaceuticals, last date for sale: June 14, 2010
Azmacort Inhalation Aerosol (triamcinolone), made by Abbott Laboratories, last date for sale: Dec. 31, 2010
Intal Inhaler (cromolyn), made by King Pharmaceuticals, last date for sale: Dec. 31, 2010
Aerobid Inhaler System (flunisolide), made by Forest Laboratories, last date for sale: June 30, 2011
Combivent Inhalation Aerosol (albuterol and ipratropium in combination), made by Boehringer Ingelheim Pharmaceuticals, last date for sale: Dec. 31, 2013
Maxair Autohaler (pirbuterol), made by Graceway Pharmaceuticals, last date for sale: Dec. 31, 2013
Four of the seven CFC inhalers are no longer being made. Three CFC inhalers currently in useAerobid, Combivent, and Maxairwill be phased out over the next one to three years. These later phase-out dates give patients time to talk with their health care professionals and switch to another medicine.
FDA will continue to reach out to companies, health care professionals, and patients to ensure a smooth transition.
If you use one of these CFC inhalers, talk with your health care professional and switch to a medicine that does not contain CFCs. You cannot be sure how long you will be able to buy your CFC inhaler because manufacturers may stop making them before the last day they can be sold. For example, the manufacturers of Alupent Inhalation Aerosol and Tilade Inhaler have already stopped making these drugs.
If you have an inhaler after the last day the inhaler can be sold, you may continue to use it.
CFCs harm the environment by decreasing the ozone layer above the earth. The ozone layer protects us from harmful ultraviolet radiation.
The United States and most other countries have signed an international agreement to make it illegal after certain dates to manufacture or sell substances, including CFCs, which decrease the ozone layer.
Most CFC inhalers have already been phased out as part of this agreement.
There are many other inhalers available in the United States that don’t contain CFCs. Talk to your health care professional to decide which one is right for you.
FDA will work with companies to ensure enough other medicines are available.
There are inhalers that use the propellant hydrofluoroalkane, or HFA, instead of CFCs. There are also dry powder inhalers that don’t use a propellant at all, and liquids that are used with a nebulizer machine.
These medicines to treat your asthma or COPD may look, feel, or taste different, and may be used differently than your CFC inhaler.
Ask your health care professional to show you how to use your new medicine correctly.
Talk to a health care professional about programs that can help get the medicine you need.
Check with the company that makes the medicine to see if it has a patient-assistance program that provides the medicine at no cost, or at a lower cost.